[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100452314":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":17,"locations":24,"responsibleParty":44,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Can-Am HIFU Inc.","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Aquablation",null,[12],"Procedure: Aquablation",[14],{"type":15,"name":9,"description":9,"armGroupLabels":16,"otherNames":10},"PROCEDURE",[9],[18],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},"Dean Elterman","CONTACT","4166035800","5033","dean.elterman@uhn.ca",[25],{"facility":19,"status":26,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Toronto","Ontario","M5T 2S8","Canada",{"type":32,"coordinates":33},"Point",[34,35],-79.39864,43.70643,{"lat":35,"lon":34},[38,39,42],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},{"name":40,"role":20,"phone":21,"phoneExt":41,"email":23},"Iris Chan","Elterman",{"name":19,"role":43,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":43,"investigatorFullName":19,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Urologist","100452314",false,"NCT05169892","Aquablation in Benign Prostatic Hyperplasia in Canada","Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH)\n* Male subjects of ≥ 18 years of age\n* Candidate for Aquablation therapy as per clinical decision of Investigator\n* Willing and able to accurately complete questionnaires\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.","MALE","18 Years",{"count":55,"type":56},25,"ESTIMATED","OBSERVATIONAL","To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.",[60],"Urologic Diseases",[62],"benigh prostate hypertrophy","2021-12-09",{"date":65,"type":66},"2021-12-27","ACTUAL",{"date":68,"type":66},"2019-10-09",{"date":70,"type":56},"2026-12-31",{"name":5,"class":6},1]